Another age bracket of Albertans will be able to book appointments for the AstraZenica COVID-19 vaccine starting Thursday, after more than 11,500 bookings were made Wednesday.
According to Dr. Deena Hinshaw, Albertans who were born in 1958, as well as First Nations, Metis and Inuit people born in 1973, will be eligible for an AztraZenica immunization.
The province is rolling out eligibility for its current 58,000 doses of the third vaccine to be approved in Canada based on birth year.
“If you are eligible to get the vaccine, please do so. And encourage your friends and neighbours to do so as well. The more people who become immunized, the less the virus will be able to mutate, and the less it will impact our communities.”
Story continues below advertisement
Those eligible are encouraged to book online or book in off-peak times, as 811 demand and call volume is expected to be high.
3:13 Senior Toronto scientists question 4-month delay of 2nd dose
Senior Toronto scientists question 4-month delay of 2nd dose
Hinshaw said as of Wednesday, nearly 138,000 seniors over the age of 75 who are not living in designated supported living or continuing care facilities – which were included in Phase 1A of Alberta’s vaccine rollout – have either gotten their shot or have their appointment booked.
So far, 309,000 doses of vaccine have been administered to Albertans, with 91,000 people being fully immunized against COVID-19 with two doses.
Hinshaw said it “can be tempting to let your guard down after immunization,” but stressed that more research needs to be done before health officials can determine how being vaccinated impacts viral transmission.
“Even if you have been vaccinated with one or two doses, all public health orders in place still apply,” she said.
Story continues below advertisement
Hinshaw stressed that while it’s recommended those with chronic health issues try to get a Pfizer or Moderna vaccine rather than AstraZenica, the AstraZeniva vaccine is “not unsafe” for those who suffer from chronic conditions.
“If an individual who has a chronic condition wishes to receive AstraZenica and they’re in the appropriate age group, they could choose to do so,” she said.
“There is no requirement to prove that an individual is healthy if they wish to receive AstraZenica vaccine and they are in the eligible age group.”
Those looking to book an AstraZenica vaccine appointment are encouraged to weigh their options and make the best decision for them, Hinshaw said.
0:38 AstraZeneca’s COVID-19 vaccine ‘not unsafe’ for chronic conditions: Hinshaw
AstraZeneca’s COVID-19 vaccine ‘not unsafe’ for chronic conditions: Hinshaw
Bookings for Phase 2A of the vaccine rollout is scheduled to start Monday, March 15, and will be open to those 65 to 74, no matter where they live, as well as First Nations, Metis and Inuit people 50 and older. Staff and residents of licensed supportive livings are also included.
Story continues below advertisement
However, Global News called 10 pharmacies in Edmonton currently providing immunizations, and several were already scheduling Phase 2A appointments. Hinshaw said some pharmacies have already started taking those appointments because they have stores of Pfizer vaccine that could be set to expire soon.
“We have also indicated to pharmacies that if they have doses of vaccine (that) will be expiring, that they should using those so that we don’t waste that produce,” she said.
“And so there may be pharmacies that have appointments open that haven’t been taken by those 75 plus, and then they would naturally go on to that next eligible category in order to not waste the vaccine.”
Alberta Health later said in an email that while pharmacies are taking those bookings, people are being asked to “be patient” and wait until Monday.
Hinshaw said the province is still working through the expression of interest process of getting doctors’ offices and clinics added to the list of places where vaccines can be administered. She said pharmacies have been the dominant provider of flu vaccines in Alberta, which means they already have the infrastructure in place for storage and tracking of vaccines that few clinics currently have.
Hinshaw said roughly half the current supply of AstraZenica vaccine has to be used up before April 2, with the remainder having a longer shelf life.
With the current uptake in appointments, she doesn’t forsee any issue with having those vaccines in Albertans’ arms before their expiry date.
“With respect to whether Albertans might be waiting for an mRNA vaccine — the Pfzer or the Moderna – it’s difficult to say. I do think that we have good evidence, certainly real-world evidence out of the U.K., that the AstraZenica vaccine is effective at preventing severe outcomes in the individual who receives it,” Hinshaw said.
“So I would encourage Albertans who are eligible for vaccine to look at the options and then choose the vaccine that they’re able to get as soon as they can.”
16-week gap between shots
Starting Wednesday, appointments for first and second COVID-19 vaccine doses in Alberta will be spaced up to 16 weeks apart, but one infectious diseases researcher said that may not always be the case.
The change in timing comes after a recommendation from the National Advisory Committee on Immunization (NACI), which cited evidence showing there was some protection against severe outcomes after the first dose.
Up until Wednesday, doses were being spaced out up to six weeks in Alberta, which is already more than the two- and three-week recommendations of manufacturers Pfizer and Moderna. However, it is not clear how long the province may follow the NACI recommendation of up to 16 weeks.
“It’s certainly possible that the door has been left open to be able to revert back to the timelines that were on the box, on the label, and that we have more data for,” said Dr. Ilan Schwartz, an infectious diseases researcher at the University of Alberta.
“That said, from the standpoint of getting as many people as quickly as possible, it does make sense to hold off on those first doses initially, based on the data that has emerged. But I think as supply ramps up and starts to catch up with demand, I think certainly there could be a situation where that recommendation is relaxed.”
Schwartz said it may be possible to see large windows where people can select their date for a follow-up appointment.
Case numbers
Alberta labs confirmed an additional 399 new COVID-19 infections over the last 24 hours, from roughly 10,400 tests, putting the province’s positivity rate at 3.7 per cent.
Story continues below advertisement
A total of 254 people were being treated in the province’s hospitals, with 37 of them in intensive care units.
Two deaths were reported on Wednesday.
A woman in her 70s in the Calgary zone with no known comorbidities died. A woman in her 80s in the Central zone also died. Her case included comorbidities, according to Alberta Health.
1:56 Alberta identifies 47 COVID-19 variant cases Wednesday
Alberta identifies 47 COVID-19 variant cases Wednesday
Forty-seven new cases of variants of concern were also detected in the province, bringing the total number of cases since Dec. 15 to 734.
Hinshaw said the percentage of variant cases in Alberta’s total case numbers has risen slightly in six weeks, from three per cent in late January to nine per cent currently – which is significantly lower than other jurisdictions, which have seen their cases rise from three to four per cent to nearly 50 per cent in the same time frame.
Story continues below advertisement
“This means that our health measures — both the overall restrictions, as well as the targeted measures for variant cases – are working to slow the growth. And if we continue to work together, we can continue to limit the spread.”
TORONTO – Canada Goose Holdings Inc. says it has signed a deal that will result in the creation of its first eyewear collection.
The deal announced on Thursday by the Toronto-based luxury apparel company comes in the form of an exclusive, long-term global licensing agreement with Marchon Eyewear Inc.
The terms and value of the agreement were not disclosed, but Marchon produces eyewear for brands including Lacoste, Nike, Calvin Klein, Ferragamo, Longchamp and Zeiss.
Marchon plans to roll out both sunglasses and optical wear under the Canada Goose name next spring, starting in North America.
Canada Goose says the eyewear will be sold through optical retailers, department stores, Canada Goose shops and its website.
Canada Goose CEO Dani Reiss told The Canadian Press in August that he envisioned his company eventually expanding into eyewear and luggage.
This report by The Canadian Press was first published Sept. 19, 2024.
Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.
Here’s a timeline of key events in the bread price-fixing case.
Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.
Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.
Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.
Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).
Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.
June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.
Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”
Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.
July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.
Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.
This report by The Canadian Press was first published Sept. 19, 2024.
Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)
TORONTO – TD Bank Group, which is mired in a money laundering scandal in the U.S., says chief executive Bharat Masrani will retire next year.
Masrani, who will retire officially on April 10, 2025, says the bank’s, “anti-money laundering challenges,” took place on his watch and he takes full responsibility.
The bank named Raymond Chun, TD’s group head, Canadian personal banking, as his successor.
As part of a transition plan, Chun will become chief operating officer on Nov. 1 before taking over the top job when Masrani steps down at the bank’s annual meeting next year.
TD also announced that Riaz Ahmed, group head, wholesale banking and president and CEO of TD Securities, will retire at the end of January 2025.
TD has taken billions in charges related to ongoing U.S. investigations into the failure of its anti-money laundering program.
This report by The Canadian Press was first published Sept. 19, 2024.
